ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 614

The Association of PPM1A with Inflammasome Activation in Ankylosing Spondylitis

Soo Min Ahn1, Seung-Hyeon Bae1, Seokchan Hong1, Eun-Ju Lee1, Eun-Jin Lee2, Eun-Ju Chang2, Doo-Ho Lim1, Yong-Gil Kim1, Chang-Keun Lee1 and Bin Yoo1, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 2Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Inflammasome activation and inflammation

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

The Association of PPM1A with Inflammasome Activation in Ankylosing Spondylitis

Background/Purpose

Ankylosing spondylitis (AS) is a chronic inflammatory disorder usually affecting axial skeleton and joints. The pathogenesis and mechanism of inflammatory response in AS, however, remains not fully understood. Recently, it has been suggested that AS could be associated with autoinflammatory responses, which are driven by innate immunity through inflammasome activation. We have reported that immunity to protein phosphatase magnesium-dependent 1A (PPM1A), which regulate BMP and Wnt signaling, are associated with AS. In this study, we try to investigate the association of PPM1A with inflammatory response in AS and its role in the inflammasome activation.

Methods

The concentration of PPM1A was measured in the plasma from AS, rheumatoid arthritis (RA) and healthy control (HC) subjects by enzyme-linked immunosorbent assay (ELISA), and addressed the association with inflammatory burden including disease activity in AS patients. Next, the expression of intracellular PPM1A was evaluated in the synovia from patients with AS, RA and osteoarthritis and in peripheral blood mononuclear cells (PBMCs) from patients with AS, RA and HC. To know the role of PPM1A in the inflammasome activation, the production of IL-1b and expression of active caspase-1 were measured with or without PPM1A knockdown in the macrophage. The expression of PPM1A was evaluated after stimulation with various cytokines.

Results

The levels of PPM1A were significantly higher in the plasma of AS patients compared with RA or HC subjects. In addition, there was significant correlation between the levels of PPM1A in plasma and the values of BASDAI, ESR and CRP in AS patients (Figure 1). The expression of PPM1A in the synovia and PBMCs were elevated in AS. Further, IL-1b secretion and activation of caspase-1 was significantly decreased by knockdown of PPM1A. Finally, the expression of PPM1A was enhanced by stimulation with TGF-b in the macrophage.

Conclusion

Our present study suggested that inflammasome activation could be regulated by intracellular PPM1A, which contribute to the pathogenesis of inflammatory responses in AS.

Figure 1. Correlation between BASDAI (a), CRP (b) and the levels of PPM1A in the plasma of patients with AS

PPM1A-Figure1.jpg


Disclosure:

S. M. Ahn,
None;

S. H. Bae,
None;

S. Hong,
None;

E. J. Lee,
None;

E. J. Lee,
None;

E. J. Chang,
None;

D. H. Lim,
None;

Y. G. Kim,
None;

C. K. Lee,
None;

B. Yoo,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-ppm1a-with-inflammasome-activation-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology